However, in other cancer types (breast cancer and MDS), alternative splicing in PPP2R5A, MAP3K7, and IRAK4 has been linked to the activation of Akt and NF-κB pathway, TGF-β signaling, and inflammation pathway, respectively. Here, PPP2R5A is linked to cancer.